Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIDAURUS
2024-512727-36-00Phase 4Completed
- Sponsor
- LMU Klinikum
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised trial of prasugrel, clopidogrel, ticagrelor and aspirin in Atrial fibrillation (AFib), myocardial infarction (MI), Myocardial Infarction (MI) and 1 more, sponsored by LMU Klinikum. Started Oct 2024; status: completed.
02
Drugs
prasugrelclopidogrelticagreloraspirin
03
Conditions
Atrial fibrillation (AFib)myocardial infarction (MI)Myocardial Infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2024-512727-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512727-36-00.